Gateway Chemist Vaccination Centre

Gateway Chemist Vaccination Centre

We regret to inform you that our Covid-19 vaccination centre wont be able to administer first, second (primary course) vaccine until further notice from the NHS board.

 

For any other COVID-related questions, please email us at: covid.vaccination@gatewaychemist.com

COVID

THE AUTUMN BOOSTER PROGRAM IS NOW FINISHED,NO BOOSTERS AVAILABLE AS OF 13/02/2023!

ELIGIBLE GROUPS WILL BE ANNOUNCED OR INVITED BY COHORT:

  • residents in a care home for older adults and staff working in care homes for older adults
  • frontline health and social care workers
  • all adults aged 50 years and over
  • persons aged 5 to 49 years in a clinical risk group, as set out in Tables 3 and 4
  • persons aged 5 to 49 years who are household contacts of people with immunosuppression (as defined in Tables 3 and 4)
  • persons aged 16 to 49 years who are carers (as defined in Table 3).

The booster should ideally be offered from September, allowing a minimum of three months from the previous dose.

The programme would prioritise delivery to those aged over 75 years and in care homes for older adults but recognising the need for operational flexibility based on the likely delivery models. The aim should be to complete the campaign before December to provide additional protection in time for the expected winter peak of other seasonal viruses. Someone in the eligible groups above who has received a full course of primary vaccination (two or three doses) but has not received a booster before September 2022, may be given the autumn booster in the campaign provided there is at least three months from the previous dose.

Additional doses are not then required.

1. Eligibility

  • Residents in a care home for older adults and staff working in care homes for older adults
  • Frontline Healthcare Staff: “Staff involved in direct patient care This includes staff who have frequent face-to-face clinical contact with patients and who are directly involved in patient care in either secondary or primary care/community settings. This includes doctors, dentists, midwives and nurses, paramedics and ambulance staff, pharmacists, optometrists, occupational therapists, physiotherapists and radiographers It should also include those working in independent, voluntary and non-standard healthcare settings such as hospices, and community-based mental health or addiction services. Staff working on the COVID vaccination programme, temporary staff, students, trainees and volunteers who are working with patients must also be included.” – Please download and complete this form, to be brought in for your vaccine appointment, then call us on: 02083491094, or email us on: covid.vaccination@gatewaychemist.com or text us on: 07365711905, we need name, organisation, date of birth and NHS number.
  • Social Care Workers and other carers: “This would include:
    • those working in long-stay residential and nursing care homes or other long-stay care facilities where rapid spread is likely to follow introduction of infection and cause high morbidity and mortality
    • social care staff directly involved in the care of their patients or clients
    • others involved directly in delivering social care such that they and vulnerable patients/ clients are at increased risk of exposure” – Please download and complete this form, to be brought in for your vaccine appointment, we need name,organisation, date of birth and NHS number.
  • All adults aged 50 and over; 
  • Those aged 5-49 in a clinical risk group:
  • Chronic respiratory disease Individuals with a severe lung condition, including those with asthma that requires continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission, and chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema; bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD).
  • Chronic heart disease and vascular disease Congenital heart disease, hypertension with cardiac complications, chronic heart failure, individuals requiring regular medication and/or follow-up for ischaemic heart disease. This includes individuals with atrial fibrillation, peripheral vascular disease or a history of venous thromboembolism.
  • Chronic kidney disease Chronic kidney disease at stage 3, 4 or 5, chronic kidney failure, nephrotic syndrome, kidney transplantation.
  • Chronic liver disease Cirrhosis, biliary atresia, chronic hepatitis.
  • Chronic neurological disease Stroke, transient ischaemic attack (TIA). Conditions in which respiratory function may be compromised due to neurological disease (e.g. polio syndrome sufferers). This includes individuals with cerebral palsy, severe or profound learning disabilities, Down’s Syndrome, multiple sclerosis, epilepsy, dementia, Parkinson’s disease, motor neurone disease and related or similar conditions; or hereditary and degenerative disease of the nervous system or muscles; or severe neurological disability.
  • Diabetes mellitus Any diabetes, including diet-controlled diabetes.
  • Immunosuppression Immunosuppression due to disease or treatment, including patients undergoing chemotherapy leading to immunosuppression, patients undergoing radical radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients, HIV infection at all stages, multiple myeloma or genetic disorders affecting the immune system (e.g. IRAK-4, NEMO, complement disorder, SCID). Individuals who are receiving immunosuppressive or immunomodulating biological therapy including, but not limited to, anti-TNF, alemtuzumab, ofatumumab, rituximab, patients receiving protein kinase inhibitors or PARP inhibitors, and individuals treated with steroid sparing agents such as cyclophosphamide and mycophenolate mofetil. Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg or more per day for adults. Anyone with a history of haematological malignancy, including leukaemia, lymphoma, and myeloma and those with systemic lupus erythematosus and rheumatoid arthritis, and psoriasis who may require long term immunosuppressive treatments. Most of the more severely immunosuppressed individuals in this group should already be flagged as CEV. Individuals who are not yet on the CEV list but who are about to receive highly immunosuppressive interventions or those whose level of immunosuppression is about to increase may be therefore be offered vaccine alongside the CEV group, if therapy can be safely delayed or there is sufficient time (ideally two weeks) before therapy commences. Some immunosuppressed patients may have a suboptimal immunological response to the vaccine (see Immunosuppression and HIV).
  • Those aged 5-49 who are household contacts of people with immunosuppression
  • Asplenia or dysfunction of the spleen This also includes conditions that may lead to splenic dysfunction, such as homozygous sickle cell disease, thalassemia major and coeliac syndrome.
  • Morbid obesity Adults with a Body Mass Index ≥40 kg/m².
  • Severe mental illness Individuals with schizophrenia or bipolar disorder, or any mental illness that causes severe functional impairment.
  • Adult carers Those who are eligible for a carer’s allowance, or those who are the sole or primary carer of an elderly or disabled person who is at increased risk of COVID-19 mortality and therefore clinically vulnerable,and who have been sent a letter by the NHS to book,after registering as main carer with the person’s GP.
  • Younger adults in long-stay nursing and residential care settings. Many younger adults in residential care settings will be eligible for vaccination because they fall into one of the clinical risk groups above (for example learning disabilities). Given the likely high risk of exposure in these settings, where a high proportion of the population would be considered eligible, vaccination of the whole resident population is recommended. Younger residents in care homes for the elderly will be at high risk of exposure, and although they may be at lower risk of mortality than older residents should not be excluded from vaccination programmes
  • Pregnancy; all stages (first, second, and third trimesters)

COVID

2. How do I know if I have been selected?

3. What facilities are available in our vaccination centre?

  • Step free access
  • Toilet Access
  • Wheelchair access
  • Ability to communicate by text on phones
  • Disabled street parking out front and on nearby streets

4. What information do I need when I arrive at my appointment?

  • Please bring with you, your booking reference, NHS Number, D.O.B, and it may help to bring some form of  photo ID.

5. What happens if I am late or miss my appointment?

  • The NHS have made improvements to the cancellation and amending appointments. Patients can either cancel or amend their appointments, by logging back into www.nhs.uk/covid-vaccination , or by calling 119.  We would like  to remind patients that this functionality exists, particularly for the second dose appointment. Please note that patients are unable to cancel or amend their appointments on the day they made their appointment, or the day they are booked in to attend.

6. How can I change my appointment?

7. How do I volunteer?

8. What if I have COVID symptoms or other illnesses?

  • Please do not enter our vaccination centre if you are experiencing any COVID-like symptoms, as you will be putting everyone at risk.

10. What if I have experienced symptoms or have had COVID recently?

  • The current recommendation is to wait 4 weeks after receiving a positive test or experiencing symptoms, before getting vaccinated, and 12 weeks for those under 18 years of age.

COVID Incubation Timeline

11. How do I get to your pharmacy

a. Parking

  • We have pay-as-you-go street parking out front and  free parking ,but not between 2-3pm on nearby streets, please check parking bay areas.
  • Please do not block access or park on double yellow lines

b. Public transport

  • Our address is: 334A Regent’s Park Rd, Finchley, London N3 2LN
  • We are 3 mins walk from Finchley Central Station (Northern Line)
  • There are several bus routes that stop nearby.

12. Are there any side effects to the vaccination?

13. What should I do if I am suffering from the side effects of the vaccination?

  • Please phone your doctor, pharmacist, or call 111

Please review our service us on Google Reviews or NHS Choices. Thank You.